{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:16:24Z","timestamp":1768810584015,"version":"3.49.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ygyno.2018.01.034","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T03:11:24Z","timestamp":1519960284000},"page":"410-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ongoing strategies and updates on pain management in gynecologic oncology patients"],"prefix":"10.1016","volume":"149","author":[{"given":"Kari E.","family":"Hacker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Kevin","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitanshu","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.01.034_bb0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.2017.0935","article-title":"History of the Joint Commission's pain standards: lessons for today's prescription opioid epidemic","volume":"317","author":"Baker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jama.284.4.423b","article-title":"JCAHO pain management standards are unveiled","volume":"284","author":"Phillips","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amepre.2015.02.020","article-title":"Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007\u20132012","volume":"49","author":"Levy","year":"2015","journal-title":"Am. J. Prev. Med."},{"issue":"26","key":"10.1016\/j.ygyno.2018.01.034_bb0020","first-page":"563","article-title":"Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines\u2014United States, 2012","volume":"63","author":"Paulozzi","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0025","unstructured":"Understanding the Epidemic | Drug Overdose | CDC Injury Center, (2017). https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html (accessed December 7, 2017)."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain \u2014 United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0035","series-title":"Pain Management and the Opioid Epidemic","author":"Committee on Pain Management and Regulatory Strategies to Address Opioid Abuse, Board on Health Sciences Policy, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"issue":"36","key":"10.1016\/j.ygyno.2018.01.034_bb0040","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2017.74.1363","article-title":"New persistent opioid use among patients with cancer after curative-intent surgery","volume":"35","author":"Lee","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0045","series-title":"Clinical Practice Guidelines in Oncology, Adult Cancer Pain","author":"NCCN","year":"2017"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ygyno.2016.11.015","article-title":"Opioid use in gynecologic oncology; balancing efficacy, accessibility and safety: an SGO clinical practice statement","volume":"144","author":"Lefkowits","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1188\/15.CJON.19-05AP","article-title":"A systematic review of nonpharmacologic interventions for treatment-related symptoms in women with ovarian cancer","volume":"19","author":"Davis","year":"2015","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0060","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: systematic review and meta-analysis","volume":"51","author":"van den Beuken-van Everdingen","year":"2016","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0065","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1200\/JCO.2014.56.0383","article-title":"Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer","volume":"32","author":"Greco","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0070","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/prca.201100015","article-title":"Surveying proteolytic processes in human cancer microenvironments by microdialysis and activity-based mass spectrometry","volume":"5","author":"Hardt","year":"2011","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pain.2010.02.010","article-title":"Serine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway","volume":"149","author":"Lam","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0080","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/1073858414525828","article-title":"The neurobiology of cancer pain","volume":"20","author":"Schmidt","year":"2014","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0085","doi-asserted-by":"crossref","first-page":"945","DOI":"10.12688\/f1000research.10817.1","article-title":"Recent advances in understanding and managing cancer pain","volume":"6","author":"Chwistek","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1124\/mi.10.3.7","article-title":"Mechanism of cancer pain","volume":"10","author":"Schmidt","year":"2010","journal-title":"Mol. Interv."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/SPC.0000000000000140","article-title":"Neuroimmune mechanisms in cancer pain","volume":"9","author":"Brown","year":"2015","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0100","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mehy.2006.01.015","article-title":"Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis","volume":"67","author":"Entschladen","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc747","article-title":"Molecular mechanisms of cancer pain","volume":"2","author":"Mantyh","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/01.AOG.0000127983.70739.d8","article-title":"The gynecologic oncology consult: symptom presentation and concurrent symptoms of depression and anxiety","volume":"103","author":"Fowler","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jncimonographs\/lgh014","article-title":"Prevalence of depression in patients with cancer","author":"Massie","year":"2004","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0125","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/bjc.2012.364","article-title":"Incidence and drug treatment of emotional distress after cancer diagnosis: a matched primary care case-control study","volume":"107","author":"Desplenter","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0130","first-page":"9565","article-title":"Biopsychosocial predictors of pain among women recovering from surgery for gynecologic cancer","volume":"32","author":"Honerlaw","year":"2014","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0135","first-page":"851276","article-title":"Depression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancer","volume":"2012","author":"Galloway","year":"2012","journal-title":"Pain Res. Treat."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0140","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1200\/JCO.2013.54.4825","article-title":"Psychological and behavioral approaches to cancer pain management","volume":"32","author":"Syrjala","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0145","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0885-3924(02)00497-9","article-title":"Cancer pain and psychosocial factors: a critical review of the literature","volume":"24","author":"Zaza","year":"2002","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0150","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0155","doi-asserted-by":"crossref","first-page":"ES39","DOI":"10.36076\/ppj.2012\/15\/ES39","article-title":"A systematic review of randomized trials on the effectiveness of opioids for cancer pain","volume":"15","author":"Koyyalagunta","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0160","article-title":"Opioids for cancer pain \u2014 an overview of Cochrane reviews","volume":"7","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0165","author":"WHO"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0170","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1200\/JCO.2010.32.6884","article-title":"Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study","volume":"29","author":"Kurita","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2018.01.034_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011056","article-title":"Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain","volume":"29","author":"Wiffen","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012638","article-title":"Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults","volume":"7","author":"Derry","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0190","article-title":"Oral paracetamol (acetaminophen) for cancer pain","volume":"7","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0195","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1200\/JCO.2013.52.8356","article-title":"Nonopioid drugs in the treatment of cancer pain","volume":"32","author":"Vardy","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0200","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pain.2011.10.028","article-title":"Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review","volume":"153","author":"Bennett","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0210","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0269216310378546","article-title":"Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review","volume":"25","author":"Bennett","year":"2011","journal-title":"Palliat. Med."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0215","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1533-2500.2011.00485.x","article-title":"Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature","volume":"12","author":"Vadalouca","year":"2012","journal-title":"Pain Pract."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0220","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpainsymman.2012.10.230","article-title":"The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects","volume":"46","author":"Jongen","year":"2013","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0225","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0269216317711826","article-title":"Opioids combined with antidepressants or antiepileptic drugs for cancer pain: systematic review and meta-analysis","volume":"32","author":"Kane","year":"2018","journal-title":"Palliat. Med."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0230","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/papr.12459","article-title":"National guideline working group \u201cdiagnosis treatment of cancer pain,\u201d pharmacological treatment of pain in cancer patients: the role of adjuvant analgesics, a systematic review","volume":"17","author":"van den Beuken-van Everdingen","year":"2017","journal-title":"Pain Pract."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0235","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1526-4637.2007.00325.x","article-title":"Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study","volume":"9","author":"Tsavaris","year":"2008","journal-title":"Pain Med."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0240","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/0269216308089304","article-title":"Gabapentin for breakthrough pain due to bone metastases","volume":"22","author":"Caraceni","year":"2008","journal-title":"Palliat. Med."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0245","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/AJP.0000000000000014","article-title":"Beyond neuropathic pain: gabapentin use in cancer pain and perioperative pain","volume":"30","author":"Yan","year":"2014","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1049909111412539","article-title":"A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study","volume":"29","author":"Mishra","year":"2012","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0255","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/papr.12045","article-title":"Pregabalin vs. opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label study","volume":"14","author":"Raptis","year":"2014","journal-title":"Pain Pract."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0260","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/157015912800604489","article-title":"Melatonin in antinociception: its therapeutic applications","volume":"10","author":"Srinivasan","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0265","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0270","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.mayocp.2015.08.009","article-title":"Cancer pain management","volume":"90","author":"Smith","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.TPM.0000488727.32096.c9","article-title":"Neuromodulation of cancer pain: current concepts and treatment strategies","volume":"31","author":"Patel","year":"2016","journal-title":"Topics Pain Manage."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0280","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0304-3959(91)90110-J","article-title":"Epidural opiates and local anesthetics for the management of cancer pain","volume":"46","author":"Hogan","year":"1991","journal-title":"Pain"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0285","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<2015::AID-CNCR19>3.0.CO;2-R","article-title":"Outcome and complications of epidural analgesia in patients with chronic cancer pain","volume":"83","author":"Smitt","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0290","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1196\/annals.1414.033","article-title":"Cancer pain and analgesia","volume":"1138","author":"Christo","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0295","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11916-013-0391-2","article-title":"Considerations for evaluating the use of intrathecal drug delivery in the oncologic patient","volume":"18","author":"Gulati","year":"2014","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0300","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","article-title":"Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival","volume":"20","author":"Smith","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0305","first-page":"664","article-title":"Dose changes in long- and medium-term intrathecal morphine therapy of cancer pain","volume":"31","author":"Schultheiss","year":"1992","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0885-3924(94)90159-7","article-title":"Spinal analgesia in terminal care: risk versus benefit","volume":"9","author":"Devulder","year":"1994","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0315","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/pm\/pnw060","article-title":"Intrathecal therapy for cancer-related pain","volume":"17","author":"Bruel","year":"2016","journal-title":"Pain Med."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0320","first-page":"345","article-title":"Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain","volume":"12","author":"Patel","year":"2009","journal-title":"Pain Physician"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0325","first-page":"117","article-title":"Long-term spinal analgesic delivery: a review of the preclinical and clinical literature","volume":"25","author":"Wallace","year":"2000","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0330","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/204946371000400103","article-title":"Depression and anxiety in pain","volume":"4","author":"Woo","year":"2010","journal-title":"Rev Pain."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009389.pub3","article-title":"Spinal cord stimulation for cancer-related pain in adults","author":"Peng","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SPC.0b013e32835017e7","article-title":"Interventional management of cancer pain","volume":"6","author":"Bhaskar","year":"2012","journal-title":"Curr. Opin. Support. Palliat. Care"},{"issue":"1","key":"10.1016\/j.ygyno.2018.01.034_bb0345","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007753.pub2","article-title":"Acupuncture for cancer pain in adults","volume":"19","author":"Paley","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0350","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/acu.2012.0904","article-title":"The feasibility and effects of acupuncture on quality of life scores during chemotherapy in ovarian cancer: results from a pilot, randomized sham-controlled trial","volume":"24","author":"Lu","year":"2012","journal-title":"Med. Acupunct."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0355","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0360","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/SLA.0000000000001993","article-title":"Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures","volume":"265","author":"Hill","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0365","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jhsa.2012.01.035","article-title":"Opioid consumption following outpatient upper extremity surgery","volume":"37","author":"Rodgers","year":"2012","journal-title":"J. Hand Surg. [Am.]"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0370","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000002198","article-title":"An educational intervention decreases opioid prescribing after general surgical operations","author":"Hill","year":"2017","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.ygyno.2018.01.034_rf0370","article-title":"Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain","volume":"8","author":"Derry","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2018.01.034_rf0375","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010107.pub2","article-title":"Single dose oral ibuprofen plus oxycodone for acute postoperative pain in adults","author":"Derry","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0385","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2016.04.061","article-title":"Liposomal bupivacaine reduces total opioid requirements, rescue IV opioids, and PCA use after laparotomy for gynecologic malignancies","volume":"141","author":"Kalogera","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0390","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12630-014-0275-x","article-title":"Optimizing pain management to facilitate Enhanced Recovery After Surgery pathways","volume":"62","author":"Tan","year":"2015","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0400","unstructured":"Opioid Prescribing Recommendations for Surgery, Opioid Prescribing Recommendations for Surgery. (n.d.). https:\/\/opioidprescribing.info\/ (accessed October 22, 2017)."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0405","series-title":"Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0410","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0415","doi-asserted-by":"crossref","DOI":"10.1097\/ACO.0000000000000500","article-title":"Chemotherapy-induced peripheral neuropathy: a review of recent findings","author":"Kim","year":"2017","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0420","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.critrevonc.2015.11.014","article-title":"Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: a systematic review","volume":"98","author":"Brami","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0425","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jpainsymman.2013.02.010","article-title":"Advising patients on the use of non-herbal nutritional supplements during cancer therapy: a need for doctor-patient communication","volume":"46","author":"Ben-Arye","year":"2013","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0430","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1345\/aph.1L179","article-title":"Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy","volume":"42","author":"Amara","year":"2008","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0435","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ejca.2008.04.018","article-title":"Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies","volume":"44","author":"Wolf","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0440","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0445","doi-asserted-by":"crossref","DOI":"10.1089\/acm.2017.0052","article-title":"Treatment of chemotherapy-induced peripheral neuropathy in integrative oncology: a survey of acupuncture and oriental medicine practitioners","author":"Lu","year":"2017","journal-title":"J. Altern. Complement. Med."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0450","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bmj.331.7508.70-b","article-title":"FDA warns that antidepressants may increase suicidality in adults","volume":"331","author":"Lenzer","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0455","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0460","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1078155215627502","article-title":"Taxane-induced arthralgia and myalgia: a literature review","volume":"23","author":"Chiu","year":"2017","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0465","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00520-015-2941-0","article-title":"Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy\u2014a systematic review","volume":"24","author":"Fernandes","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0470","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2013.08.006","article-title":"The five \u201cWs\u201d for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs)","volume":"89","author":"Lambertini","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0475","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/1078155215585188","article-title":"Pegfilgrastim use and bone pain: a cohort study of community-based cancer patients","volume":"22","author":"Pawloski","year":"2016","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0480","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Paice","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0485","series-title":"Clinical Practice Guideline, Survivorship","author":"NCCN","year":"2017"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0490","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jmig.2012.03.009","article-title":"Abdominal wall nerve injury during laparoscopic gynecologic surgery: incidence, risk factors, and treatment outcomes","volume":"19","author":"Shin","year":"2012","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0495","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0002-9378(87)80184-9","article-title":"Nerve entrapment after Pfannenstiel incision","volume":"157","author":"Sippo","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0500","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ca.22592","article-title":"Retroperitoneal course of iliohypogastric, ilioinguinal, and genitofemoral nerves: a study to improve identification and excision during triple neurectomy","volume":"28","author":"Geh","year":"2015","journal-title":"Clin. Anat."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0505","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5812\/traumamon.6581","article-title":"Effect of ilioinguinal neurectomy on chronic pain following herniorrhaphy","volume":"17","author":"Khoshmohabat","year":"2012","journal-title":"Trauma Mon."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0510","first-page":"504","article-title":"Prevalence of myofascial chronic pelvic pain and the effectiveness of pelvic floor physical therapy","volume":"58","author":"Bedaiwy","year":"2013","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0515","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pmr.2017.03.005","article-title":"Myofascial pelvic pain and related disorders","volume":"28","author":"Bonder","year":"2017","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0520","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/j.jmig.2015.08.864","article-title":"Transvaginal trigger point injections for pelvic floor myofascial spasm: a retrospective review of pain assessment and development of a treatment algorithm","volume":"22","author":"Fouad","year":"2015","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0525","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/AOG.0000000000000372","article-title":"Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life","volume":"124","author":"Yost","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0530","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.avsg.2017.03.197","article-title":"Lower extremity lymphedema management after gynecologic cancer surgery: a review of current management strategies","volume":"44","author":"Bakar","year":"2017","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0535","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejogrb.2017.02.021","article-title":"Lymphedema after treatment for endometrial cancer \u2014 a review of prevalence and risk factors","volume":"211","author":"Lindqvist","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0540","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1464-410X.2011.10550.x","article-title":"Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis","volume":"109","author":"Shao","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0545","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s40265-015-0443-5","article-title":"A practical approach to the management of radiation-induced hemorrhagic cystitis","volume":"75","author":"Liem","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ygyno.2018.01.034_bb0550","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrurol.2010.23","article-title":"Management of radiation cystitis","volume":"7","author":"Smit","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0555","first-page":"4","article-title":"A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach","volume":"29","author":"Feldmeier","year":"2002","journal-title":"Undersea Hyperb. Med."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0560","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11764-016-0585-9","article-title":"Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors","volume":"11","author":"Carter","year":"2017","journal-title":"J. Cancer Surviv."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0565","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/SLA.0000000000002133","article-title":"It's time to adopt electronic prescriptions for opioids","volume":"265","author":"Gawande","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0570","unstructured":"What States Need to Know about PDMPs | Drug Overdose | CDC Injury Center, (2017). https:\/\/www.cdc.gov\/drugoverdose\/pdmp\/states.html (accessed October 28, 2017)."},{"key":"10.1016\/j.ygyno.2018.01.034_bb0575","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818300738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818300738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T03:32:44Z","timestamp":1660534364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818300738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0090825818300738"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.034","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ongoing strategies and updates on pain management in gynecologic oncology patients","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}